Apomorphine is a non-selective dopamine agonist which activates both D2-like and, to a much lesser extent, D1-like receptors. It also acts as an antagonist of 5-HT2 and α-adrenergic receptors with high affinity. The compound is historically a morphine decomposition product made by boiling morphine with concentrated acid, hence the -morphine suffix. Apomorphine does not actually contain morphine or its skeleton, nor does it bind to opioid receptors.
Market Analysis and Insights: Global Apomorphine Hydrochloride Injection Market
The global Apomorphine Hydrochloride Injection market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Apomorphine Hydrochloride Injection Scope and Segment
The global Apomorphine Hydrochloride Injection market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Apomorphine Hydrochloride Injection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
The major regions covered in the report are North America, Europe, Asia-Pacific, South America, Middle East & Africa, etc. The report has specifically covered major countries including U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. It includes revenue and volume analysis of each region and their respective countries for the forecast years. It also contains country-wise volume and revenue from the year 2015 to 2020. Additionally, it provides the reader with accurate data on volume sales according to the consumption for the same years.
By the product type, the market is primarily split into
Pen Injectors
Infusion Pumps
By the end users/application, this report covers the following segments
Parkinson Disease
Erectile Dysfunction
Competitive Landscape:
The report provides a list of all the key players in the Apomorphine Hydrochloride Injection market along with a detailed analysis of the strategies, which the companies are adopting. The strategies mainly include new product development, research, and development, and also provides revenue shares, company overview, and recent company developments to remain competitive in the market.
The Apomorphine Hydrochloride Injection key manufacturers in this market include:
Supernus Pharmaceuticals
Britannia Pharmaceuticals STADA
Ever Pharma
Evolan Pharma AB (PharmSwed)
Summary:
Get latest Market Research Reports on COVID-19 Impact on Global Apomorphine Hydrochloride Injection. Industry analysis & Market Report on COVID-19 Impact on Global Apomorphine Hydrochloride Injection is a syndicated market report, published as COVID-19 Impact on Global Apomorphine Hydrochloride Injection Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Apomorphine Hydrochloride Injection market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.